Back to search
LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A) trials you may qualify forThe goal of this observational study is to understand how young children with LAMA2-related dystrophy move and change over time. We will also learn about how th…
The goal of this observational study is to learn about the natural history and multi-organ involvement of Laminin-Alpha-2-Related Dystrophy (LAMA2-RD) in pediat…
The objective of this natural history study is to comprehensively characterize the disease progression and clinical features of LAMA2-related dystrophies (LAMA2…
This retrospective chart review study of 75-120 LAMA2-CMD patients will expand the investigators understanding of the natural history of this disease. Current a…
Laminin alpha-2 (LAMA2)-related muscular dystrophy (LAMA2-MD, Merosin Deficient CMD) is a form of congenital muscular dystrophy (CMD). A person with LAMA2-MD wi…